Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELAS PHARMACIE KAMINSKI : revenue, balance sheet and financial ratios

SELAS PHARMACIE KAMINSKI is a French company founded 4 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75006), this company of category PME shows in 2024 a net income positive of 12 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS PHARMACIE KAMINSKI (SIREN 912556081)
Indicator 2024
Revenue N/C
Net income 12 106 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2024, SELAS PHARMACIE KAMINSKI generates positive net income of 12 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

12 106 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -6%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

-6.384%

Solvency indicators evolution
SELAS PHARMACIE KAMINSKI

Sector positioning

Debt ratio
0.0 2024
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Excellent

In 2024, the debt ratio of SELAS PHARMACIE KAMINSKI (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-6.38% 2024
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch

In 2024, the financial autonomy of SELAS PHARMACIE KAMINSKI (-6.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Positioning of SELAS PHARMACIE KAMINSKI in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELAS PHARMACIE KAMINSKI is estimated at 169 008 € (range 117 694€ - 252 846€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
117k€ 169k€ 252k€
169 008 € Range: 117 694€ - 252 846€
NAF 5 année 2024

Valuation method used

Net Income Multiple
12 106 € × 14.0x = 169 009 €
Range: 117 695€ - 252 847€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS PHARMACIE KAMINSKI with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS PHARMACIE KAMINSKI

What is the revenue of SELAS PHARMACIE KAMINSKI ?

The revenue of SELAS PHARMACIE KAMINSKI is not publicly disclosed (confidential accounts filed with INPI).

Is SELAS PHARMACIE KAMINSKI profitable?

Yes, SELAS PHARMACIE KAMINSKI generated a net profit of 12 k€ in 2024.

Where is the headquarters of SELAS PHARMACIE KAMINSKI ?

The headquarters of SELAS PHARMACIE KAMINSKI is located in PARIS (75006), in the department Paris.

Where to find the tax return of SELAS PHARMACIE KAMINSKI ?

The tax return of SELAS PHARMACIE KAMINSKI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS PHARMACIE KAMINSKI operate?

SELAS PHARMACIE KAMINSKI operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.